IRMD
IRMD
NASDAQ · Health Care

Iradimed Corp

$87.15
+3.71 (+4.45%)
As of May 9, 1:36 AM ET ·
Financial Highlights (FY 2026)
Revenue
82.26M
Net Income
22.06M
Gross Margin
76.7%
Profit Margin
26.8%
Rev Growth
+16.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 76.7% 76.7% 64.3% 64.3%
Operating Margin 31.2% 28.1% 20.9% 21.7%
Profit Margin 26.8% 25.5% 19.7% 18.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 82.26M 70.74M 371.28M 367.15M
Gross Profit 63.14M 54.29M 238.61M 235.95M
Operating Income 25.67M 19.86M 77.66M 79.60M
Net Income 22.06M 17.08M 73.06M 68.53M
Gross Margin 76.7% 76.7% 64.3% 64.3%
Operating Margin 31.2% 28.1% 20.9% 21.7%
Profit Margin 26.8% 25.5% 19.7% 18.7%
Rev Growth +16.3% +16.3% +3.1% +13.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 192.97M 209.74M
Total Equity 936.02M 858.01M
D/E Ratio 0.21 0.24
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 27.01M 22.06M 107.10M 104.64M
Free Cash Flow 59.94M 58.81M